PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Vitamin B12 supplements may help treat hepatitis C

Safe and inexpensive option for boosting response rate to antiviral drugs

2012-07-18
(Press-News.org) Adding vitamin B12 to standard hepatitis C virus (HCV) treatment significantly boosts the body's ability to keep the virus at bay, indicates a pilot study published online in the journal Gut.

The effects were particularly strong in patients whose infection was proving difficult to treat effectively, the findings showed.

Between 60% and 80% of those infected with the viral liver infection HCV will go on to develop chronic hepatitis, and roughly a third of them will progress to cirrhosis and terminal liver disease.

Standard treatment of interferon (peg IFN) and ribavarin clears the virus in about 50% of patients infected with genotype 1 HCV and 80% of those infected with genotypes 2 or 3.

But this approach fails to clear the virus in around half of all those infected with HCV or the infection returns once treatment stops.

While trials of new generation antiviral drugs show promise, they are expensive, and can make treatment more difficult. And questions still remain about how well they will work in practice, say the authors.

Experimental research dating back a decade suggests that vitamin B12 may have a role in suppressing HCV. The liver is the body's primary storage centre for vitamin B12, but this capacity is impaired by diseases directly affecting the organ.

The researchers therefore wanted to see if adding vitamin B12 to standard treatment would make a difference.

Ninety four patients with HCV infection were randomly allocated to receive standard treatment or standard treatment plus vitamin B12 (5000 ug every 4 weeks) for between 24 (genotypes 2 and 3) and 48 weeks (genotype 1).

The body's ability to clear the virus was assessed after 4 weeks (rapid viral response), after 12 weeks (complete early viral response), at the end of treatment and at 24 weeks after stopping treatment (sustained viral response).

There was no difference between the two treatment approaches at 4 weeks, but there were significant differences in response at all the other time points, particularly 24 weeks after stopping treatment, which is the aim of HCV treatment and the closest it can be get to a cure.

The effects were also significantly greater among those who carried the type 1 strain, which is particularly hard to treat, and those high levels of infection (high viral load) to begin with.

Overall, adding vitamin B12 to standard therapy strengthened the rate of sustained viral response by 34%, the findings showed.

The authors conclude that until clear eligibility criteria for treatment with the new generation antiviral drugs are established, standard treatment plus vitamin B12 is a safe and inexpensive alternative, particularly for those who carry a strain of the virus that is hard to treat.

They add: "This strategy would be especially useful in those countries where, owing to limited economic means, the new generation antiviral therapies cannot be given in routine practice."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Man-made pores mimic important features of natural pores

2012-07-18
BUFFALO, N.Y. -- Inspired by nature, an international research team has created synthetic pores that mimic the activity of cellular ion channels, which play a vital role in human health by severely restricting the types of materials allowed to enter cells. The pores the scientists built are permeable to potassium ions and water, but not to other ions such as sodium and lithium ions. This kind of extreme selectivity, while prominent in nature, is unprecedented for a synthetic structure, said University at Buffalo chemistry professor Bing Gong, PhD, who led the study. The ...

Widely prescribed MS treatment may not slow progression of disease: VCH-UBC research

2012-07-18
Researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of British Columbia have published important data in the Journal of the American Medical Association (JAMA) about the impact of a common drug therapy on the progression of multiple sclerosis for people with the relapsing‑remitting form of the disease. The study, led by Drs. Helen Tremlett, Afsaneh Shirani, Joel Oger and others, shows no strong evidence that a group of drugs, beta interferons (β-IFNs), prescribed to treat MS had a measurable ...

New video series highlights the people who fuel America's innovation pipeline

2012-07-18
The researchers reflect on their work as well as how the U.S. system for funding research makes the United States a leader. "Because of the opportunities provided by federal research funding, we are developing a generation of scientists that has no competitor on planet Earth," says Erik Dutson, executive medical director of the Center for Advanced Surgical and Interventional Technology at the University of California, Los Angeles. They also talk about the risks of decreased funding. "If you have a population of scientists that [don't] have the resources to train the ...

Girls with eating disorders regain healthy fatty acid levels when their weight normalizes

2012-07-18
A study of teenage girls with eating disorders has shown that reduced essential fatty acid levels returned to normal once the girls increased their weight to a healthy level. The research, published in the August issue of Acta Paediatrica, suggests that it is not necessary to give omega-3 polyunsaturated fatty acid supplements to adolescent girls with eating disorders. "Essential fatty acid status is altered in eating disorders that result in weight loss" explains co-author Dr Ingemar Swenne from Uppsala University Children's Hospital. "This is important because ...

Scientists find new way to induce programmed cell death, or apoptosis

2012-07-18
Researchers from the Hebrew University of Jerusalem and the Weizmann Institute of Science have developed a technique to cause apoptosis, or programmed cell death, that could lead to new approaches to treating cancer. Apoptosis is an essential defense mechanism against the spread of abnormal cells such as cancer. It is a complex process that occurs through networks of proteins that interact with each other. Cancer cells usually avoid this process due to mutations in the genes that encode the relevant proteins. The result is that the cancer cells survive and take over while ...

What it takes to be the perfect invading parasite

2012-07-18
Scientists from the Zoological Society of London (ZSL) are the first to document the characteristics of invading parasites, using malaria in New Zealand bird species. The study, published today in Ecology Letters, identifies the factors influencing the success of parasites unintentionally introduced to new environments. Avian malaria is a disease caused by species of parasites, of the genus Plasmodium, which infects birds. Just like human malaria, it is spread by mosquitoes, and the parasites spend part of their lives in red blood cells of birds. Avian malaria is common ...

In search of the key word

2012-07-18
Human beings have the ability to convert complex phenomena into a one-dimensional sequence of letters and put it down in writing. In this process, keywords serve to convey the content of the text. How letters and words correlate with the subject of a text is something Eduardo Altmann and his colleagues from the Max Planck Institute for the Physics of Complex Systems have studied with the help of statistical methods. They discovered that what denotes keywords is not the fact that they appear very frequently in a given text. It is that they are found in greater numbers only ...

Marijuana use doubles risk of premature birth

2012-07-18
A large international study led by University of Adelaide researchers has found that women who use marijuana can more than double the risk of giving birth to a baby prematurely. Preterm or premature birth - at least three weeks before a baby's due date - can result in serious and life-threatening health problems for the baby, and an increased risk of health problems in later life, such as heart disease and diabetes. A study of more than 3000 pregnant women in Adelaide, Australia and Auckland, New Zealand has detailed the most common risk factors for preterm birth. ...

Infants' recognition of speech more sophisticated than previously known, NYU researchers find

2012-07-18
The ability of infants to recognize speech is more sophisticated than previously known, researchers in New York University's Department of Psychology have found. Their study, which appears in the journal Developmental Psychology, showed that infants, as early as nine months old, could make distinctions between speech and non-speech sounds in both humans and animals. "Our results show that infant speech perception is resilient and flexible," explained Athena Vouloumanos, an assistant professor at NYU and the study's lead author. "This means that our recognition of speech ...

Marriage has different meanings for blacks and whites

2012-07-18
EAST LANSING, Mich. — Black people who are married don't appear to live any longer than black couples who simply live together, suggesting marriage doesn't boost longevity for blacks the way it does for whites, according to a large national study led by Michigan State University. "This finding implies that marriage and cohabitation have very different meanings for blacks and whites," said MSU sociologist Hui Liu, the study's lead researcher. The study, in the Journal of Marriage and Family, is the first to document mortality differences between cohabiters and married ...

LAST 30 PRESS RELEASES:

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

Pinning down the process of West Nile virus transmission

UTA-backed research tackles health challenges across ages

In pancreatic cancer, a race against time

Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers

[Press-News.org] Vitamin B12 supplements may help treat hepatitis C
Safe and inexpensive option for boosting response rate to antiviral drugs